| # | Drug | Count |
|---|---|---|
| 0 | BLINATUMOMAB | 193 |
| 1 | DEXAMETHASONE | 32 |
| 2 | DEXAMETHASONE 1.5 MG | 32 |
| 3 | CYCLOPHOSPHAMIDE | 28 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 28 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 28 |
| 6 | METHOTREXATE | 26 |
| 7 | METHOTREXATE SODIUM | 26 |
| 8 | CYTARABINE | 25 |
| 9 | FLUDARABINE PHOSPHATE | 20 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BLINATUMOMAB | 193 | 0.0180 |
| 1 | INOTUZUMAB OZOGAMICIN | 19 | 0.0064 |
| 2 | ECHINACEA (ANGUSTIFOLIA), TABEBUIA IMPETIGINOSA, HYDRASTIS CANADENSIS, GLANDULA SUPRARENALIS SUIS, THYMUS (SUIS), THYROIDINUM (SUIS), ARSENICUM ALBUM, BRYONIA (ALBA), COCCULUS INDICUS, COLCHICUM AUTUMNALE, LEDUM PALUSTRE, MERCURIUS CYANATUS, NATRUM SULPHURICUM, PULSATILLA (PRATENSIS), SEPIA, SILICEA, AFLATOXIN (B1) | 2 | 0.0028 |
| 3 | TEBENTAFUSP | 1 | 0.0017 |
| 4 | CLOFARABINE | 3 | 0.0013 |
| 5 | (DAUNORUBICIN AND CYTARABINE) LIPOSOME | 3 | 0.0012 |
| 6 | TREOSULFAN | 3 | 0.0011 |
| 7 | DASATINIB | 10 | 0.0011 |
| 8 | MOSUNETUZUMAB | 1 | 0.0009 |
| 9 | FLUDARABINE PHOSPHATE | 20 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 45 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 39 |
| 2 | Alkylating Drug [EPC] | 30 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 26 |
| 4 | CD22-directed Immunoconjugate [EPC] | 19 |
| 5 | Azole Antifungal [EPC] | 15 |
| 6 | Proteasome Inhibitor [EPC] | 14 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 11 |
| 8 | Thalidomide Analog [EPC] | 10 |
| 9 | Topoisomerase Inhibitor [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD22-directed Immunoconjugate [EPC] | 19 | 0.0064 |
| 1 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 1 | 0.0017 |
| 2 | Anthracycline Topoisomerase Inhibitor [EPC] | 3 | 0.0012 |
| 3 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 4 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 5 | Echinocandin Antifungal [EPC] | 2 | 0.0002 |
| 6 | Asparagine-specific Enzyme [EPC] | 3 | 0.0002 |
| 7 | Lipid-based Polyene Antifungal [EPC] | 2 | 0.0002 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 39 | 0.0001 |
| 9 | Cannabinoid [EPC] | 1 | 0.0001 |